Latest Takeda news, funding rounds and robotics & AI coverage. 3 articles tracked by The Robotics Media.
Takeda Pharmaceutical Company is a values-based, R&D-driven biopharmaceutical company headquartered in Tokyo. It employs more than 47,000 people across roughly 80 countries and develops therapies across gastrointestinal & inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. In July 2026 Takeda inked a $600 million generative-AI drug discovery deal with Insilico Medicine to advance candidates through its Pharma.AI platform.